A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis.
about
Human recombinant activated protein C for severe sepsisHuman recombinant protein C for severe sepsis and septic shock in adult and paediatric patientsInflammation and haemostasisHuman infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysisDrotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?Evidence-based guide to perioperative medicine.Activated protein C in sepsis: the promise of nonanticoagulant activated protein C.Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge?Innate recognition of bacteria: potential therapeutic targets for bacterial sepsis.Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells.Use of activated protein C has no avail in the early phase of acute pancreatitis.Tenecteplase for ST-elevation myocardial infarction in a patient treated with drotrecogin alfa (activated) for severe sepsis: a case report.Positive effect of septimeb™ on mortality rate in severe sepsis: a novel non antibiotic strategy.
P2860
Q24201123-4B5BEE47-4D2B-4B9E-B1CB-84088C4F40E4Q24202128-A3D47546-52A2-4751-81EE-F6230A67722BQ26823258-C4B8C5EE-7C15-4BA6-A24A-8AC7EAC1FA4AQ30481016-CFDE88F4-C2DC-4853-BC91-AE9BC07A1DA5Q33288889-21591CCF-1B3B-4D1C-B23B-96BC5B4B8003Q34568205-5C72BACD-F2F8-4484-AA97-7FAD3871C790Q36834437-7C3A78F5-848F-4186-8371-26BE03A129A5Q37241529-325BFF12-058F-43A7-97DD-7BA4E68B253AQ37355631-BB01B368-AD85-4C58-9681-0ADC20100359Q37755268-64FF1CD4-1173-401A-81AF-023D87C644C2Q39097068-FBEA67B8-8E40-42E0-890F-1619B4110059Q41137211-31FE696B-9063-40C1-B3B2-D0B93ADC0FF5Q41810222-C0070B12-62B3-49FD-8B69-160E4E92F4E9Q43007704-80BAD337-FBA0-4513-BD10-A2F411316EBA
P2860
A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A meta-analysis of controlled ...... herapy in patients with sepsis
@nl
A meta-analysis of controlled ...... erapy in patients with sepsis.
@ast
A meta-analysis of controlled ...... erapy in patients with sepsis.
@en
type
label
A meta-analysis of controlled ...... herapy in patients with sepsis
@nl
A meta-analysis of controlled ...... erapy in patients with sepsis.
@ast
A meta-analysis of controlled ...... erapy in patients with sepsis.
@en
prefLabel
A meta-analysis of controlled ...... herapy in patients with sepsis
@nl
A meta-analysis of controlled ...... erapy in patients with sepsis.
@ast
A meta-analysis of controlled ...... erapy in patients with sepsis.
@en
P2860
P356
P1476
A meta-analysis of controlled ...... erapy in patients with sepsis.
@en
P2093
Christian J Wiedermann
Nicole C Kaneider
P2860
P2888
P356
10.1186/1471-227X-5-7
P407
P577
2005-10-14T00:00:00Z
P6179
1022000458